Substitute House Bill No. 6855, also known as Public Act No. 25-101, introduces significant changes to the regulation of hemp flower sales and nonresident pharmacies in Connecticut, effective from October 1, 2025, and January 1, 2026, respectively. The bill permits individuals not licensed as cannabis establishments or moderate-THC hemp product vendors to sell hemp flower under specific conditions, including in-person assistance and age verification. It also revises definitions related to cannabis and hemp, aligning them with existing statutes. For nonresident pharmacies, the bill mandates registration with the state and compliance with new reporting standards, including the submission of inspection reports from government agencies or qualified third parties, demonstrating adherence to the latest United States Pharmacopeia standards.

Additionally, the bill amends the classification of marijuana as a controlled substance, allowing the Commissioner of Consumer Protection to adjust classifications based on federal changes. It introduces new controlled substances and clarifies the responsibilities of healthcare providers issuing certifications for the palliative use of marijuana, ensuring legal protections for those who diagnose patients with debilitating conditions. The bill also streamlines the licensing process for cannabis establishments, modifies requirements for equity joint ventures, and enhances consumer protection measures for the sale of moderate-THC hemp products, including age verification and packaging regulations. Overall, the legislation aims to improve regulatory oversight and consumer safety in the cannabis and hemp industries.

Statutes affected:
Raised Bill: 20-627
GL Joint Favorable Substitute: 20-627
File No. 618: 20-627
Public Act No. 25-101: 20-627